ArticleCancers2026

Evaluating HER2 Scoring Criteria in Endometrial Carcinoma: Gynecologic Versus Gastric Guidelines for Trastuzumab and Trastuzumab-Deruxtecan Selection.

Sharon Nofech-Mozes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.